Q2 2020 Holdings
Filed 2020-07-14 | 53 holdings | $44.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $22.7M | 185,584 | 51.4% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $14.7M | 305,000 | 33.3% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $5.4M | 36,300 | 12.2% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $1.1M | 21,500 | 2.6% |
| Horizon Therapeutics PUB LTD | SHS | G46188101 | $24.0K | 434,000 | 0.1% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $22.6K | 303,284 | 0.1% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $18.5K | 64,822 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $15.3K | 448,000 | 0.0% |
| PTC Therapuetics COM(PTCT) | COM | 69366J200 | $15.1K | 299,000 | 0.0% |
| Biogen Inc(BIIB) | COM | 09062X103 | $13.3K | 51,200 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $13.3K | 105,800 | 0.0% |
| Amgen Inc(AMGN) | COM | 031162100 | $12.0K | 52,000 | 0.0% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $10.5K | 191,600 | 0.0% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $10.3K | 452,534 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $9.8K | 88,241 | 0.0% |
| Seattle Genetics Inc | COM | 812578102 | $9.1K | 55,500 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $8.0K | 78,000 | 0.0% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $7.9K | 307,633 | 0.0% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $7.0K | 11,500 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $6.4K | 65,859 | 0.0% |
| Zogenix Inc | COM | 98978L204 | $6.2K | 236,832 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $5.0K | 43,900 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $3.5K | 21,500 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $3.1K | 45,000 | 0.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $2.4K | 39,781 | 0.0% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $2.3K | 46,500 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $2.2K | 177,433 | 0.0% |
| Turning Point Therapeutics I | COM | 90041T108 | $2.2K | 35,000 | 0.0% |
| Ascendis Pharma AS(ASND) | Sponsored ADR | 04351P101 | $2.0K | 13,800 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $1.7K | 18,000 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $1.7K | 22,000 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $1.6K | 37,600 | 0.0% |
| Immunic Inc(IMUX) | COM | 4525EP101 | $1.5K | 123,000 | 0.0% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $1.5K | 67,000 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $1.5K | 94,600 | 0.0% |
| Principia Biopharma Inc(PRNB) | COM | 74257L108 | $1.3K | 23,100 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $1.3K | 27,500 | 0.0% |
| GW Pharmaceuticals Plc | ADS | 36197T103 | $1.2K | 10,200 | 0.0% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $1.1K | 15,700 | 0.0% |
| Sutro Biopharma Inc | COM | 869367102 | $1.1K | 139,331 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM | 040047607 | $1.0K | 16,500 | 0.0% |
| Deciphera Pharmaceuticals Inc(DCPHEUR) | COM | 24344T101 | $994 | 17,000 | 0.0% |
| Momenta Pharmaceuticals Inc(MNTA) | COM | 60877T100 | $970 | 27,000 | 0.0% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $920 | 10,700 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $918 | 12,000 | 0.0% |
| Insmed Inc(INSM) | COM | 457669307 | $902 | 33,600 | 0.0% |
| FibroGen Inc(FGENEUR) | COM | 31572Q808 | $799 | 19,700 | 0.0% |
| Bluebird Bio Inc | COM | 09609G100 | $660 | 11,000 | 0.0% |
| Global Blood Therapeutics | COM | 37890U108 | $652 | 9,800 | 0.0% |
| Intra Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $579 | 23,000 | 0.0% |